Lupus 
Trial Solutions

Enhancing study success with effective trial optimization technologies and clinical expertise for Lupus trials.

Effective solutions for advancing Lupus research

Lupus affects people in different and unpredictable ways, making it difficult to develop new treatments. With Signant Health, your study team can take advantage of our extensive experience in lupus studies, leveraging a host of comprehensive clinical research solutions and scientific expertise to advance treatment development.

Why Signant Health

  • Capture Accurate, Reliable BILAG Data
  • Optimize Clinical Ratings Technique
  • Proactively Monitor Trial Data
  • Accelerate Lupus Study Start-up
  • Partner with Lupus Experts
  • Capture Accurate, Reliable BILAG Data

    Capture Accurate, Reliable BILAG Data

    Signant's novel electronic BILAG, designed with BILAG author input, improves COA data capture through intelligent eCOA technology. Our solution features simplified workflows, structured guidance, automatic error-checking, and automated scoring validation—addressing key challenges of paper assessments while ensuring data integrity and standardized administration for superior data quality.
     

  • Optimize Clinical Ratings Technique

    Optimize Clinical Ratings Technique

    Signant’s clinical ratings experts can customize a training program to help study teams address high rates of placebo response as well as data variability due to the complexities of lupus ClinROs. Don’t let these common challenges obscure signal detection in your lupus study.
     

  • Proactively Monitor Trial Data

    Proactively Monitor Trial Data 

    Our PureSignal Analytics solution enhances lupus trial endpoint reliability through real-time statistical monitoring of trial data. Using algorithms tailored to your protocol-specific endpoints, it can verify appropriate patient eligibility, monitor for inconsistencies across sites and raters, and proactively identifies data quality concerns—typically affecting 20-30% of trial data. Proven success in recent lupus trials includes detecting screening instability patterns and flare identification inconsistencies.
     

  • Accelerate Lupus Study Start-up

    Accelerate Lupus Study Start-up

    Published research suggests shorter trials can help improve lupus research outcomes. Accelerate the study startup process by obtaining informed consent, enrolling, and randomizing patients faster using Signant SmartSignals RTSM and eConsent Silver solutions. Both are designed for rapid deployment and simplified protocol amendment implementation.
     

  • Partner with Lupus Experts

    Partner with Lupus Experts

    Rely on Signant’s clinical science and medicine experts to optimize your lupus study. From advising on protocol design and study conduct elements to training raters to score complex ClinROs accurately, we provide safeguards to help lupus studies succeed.
     

Comprehensive Lupus experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Lupus trial resources
SOLUTION BROCHURE

Lupus Trial Solutions Overview


GET INSIGHTS
VIDEO

Lupus Trial Solutions



WATCH [2 MIN]
SOLUTION

Rater Training & Qualification



EXPLORE FEATURES

Accelerate your Lupus trial success

Discover how Signant's specialized solutions can address unique challenges in your current or upcoming Lupus research.